Tudor Investment Corporation »

Springworks Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.1M 24k 46.99
2025-03-31 $10M 236k 44.13
2023-12-31 $696k 19k 36.50
2023-06-30 $556k 21k 26.22
2022-06-30 $1.0M 41k 24.62
2022-03-31 $889k 16k 56.43
2021-03-31 $591k 8.0k 73.59
2019-09-30 $223k 10k 21.70

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Spdr S&P 500 Etf Trust - US ETP ETF Option Call Option (SPY)
Energy Select Sector Spdr Fund - US ETP ETF Option Call Option (XLE)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Nvidia Corp - US Equity (NVDA)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Unitedhealth Group Inc - US Equity (UNH)
Utilities Select Sector Spdr Fund - US ETP ETF Option Call Option (XLU)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Palantir Technologies Inc - US Equity (PLTR)
Oracle Corp - US Equity Option Call Option (ORCL)
Micron Technology Inc - US Equity (MU)
Goldman Sachs Group Inc/The - US Equity Option Call Option (GS)
Apple Inc - US Equity (AAPL)

View all positions for Tudor Investment Corporation

Top funds holding Springworks Therapeutics

DekaBank Deutsche Girozentrale
Advisor Group Holdings
Huntington National Bank

View all funds holding Springworks Therapeutics